Potentiation of 2-chlorodeoxyadenosine activity by bryostatin 1 in the resistant chronic lymphocytic leukemia cell line (WSU-CLL): Association with increased ratios of dCK/5'-NT and Bax/Bcl-2

Biological Chemistry

Volumn 379, Issue 10, 1998, Pages 1253-1261

  Mohammad, Ramzi M ^a   Beck, Frances W J ^a   Katato, Khalil ^a   Hamdy, Nayera ^a   Wall, Nathan ^a   Al Katib, Ayad ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

2 Chlorodeoxyadenosine; B cell; Bryostatin 1; Chronic lymphocytic leukemia; Cytosolic 5' nucleotidase; Deoxycytidine kinase; SCID mice; Xenograft

Indexed keywords

5' NUCLEOTIDASE; BRYOSTATIN 1; CLADRIBINE; DEOXYCYTIDINE KINASE; DRUG METABOLIZING ENZYME; FLUDARABINE; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DRUG METABOLISM; DRUG POTENTIATION; DRUG SENSITIVITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LEUKEMIA CELL LINE; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; SCID MOUSE;

ANIMALIA;

EID: 0031758290     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/bchm.1998.379.10.1253     Document Type: Article

References (34)

1. Aguilar-Santelises, M., Rottenberg, M., Lewin, N., Mellstedt, H., and Jondal, M. (1996). Bcl-2, Bax and p53 expression in B-CLL In relation to in vitro survival and clinical progression. Int. J. Cancer 69, 114-121.
2. Al-Katib, A., Mohammad, R.M., Dan, M., Hussein, M.E., Akhtar, A., Pettit, G.R., and Sensenbrenner, L.L. (1993). Bryostatin 1-induced hairy cell features on chronic lymphocytic leukemia cells in vitro. Exp. Hematol 21, 61-65.
3. Al-Katib, A., Smith, M.R., Kamanda, W.S., Pettit, G.R., Hamdan, M., Mohamed, A.N., Chelladurai, B., and Mohammad, R.M. (1998). Bryostatin 1 down-regulates mdr1 and potentiates vincristine cytotoxicity in diffuse large cell lymphoma xenografts. Clin. Cancer Res. 4, 1305-1314.
4. Arner, E.S.J., Spasokoukotskaja, T., and Eriksson, S. (1992). Selective assays for thymidine kinase 1 and 2 and deoxycytidine kinase and their activities in extracts from human cells and tissues. Biochem. Biophys. Res. Comm. 188, 712-718.
5. Avery, T., Rehg, J., Lumm, W., Harwood, F.C., Santana, V.M., and Blakley, R.L. (1989). Biochemical pharmacology of 2-chloro-deoxyadenosine in malignant human hematopoietic cell lines and therapeutic effects of 2-bromodeoxyadenosine in drug combinations in mice. Cancer Res. 49, 4972-4976.
6. Carrera, C.J., Terai, T., Lotz, M., Curd, J.G., Piro, L.D., Beutler, E., and Carson, D.A. (1990). Potent toxicity of 2-chlorodeoxy-adenosine toward human monocytes in vitro and in vivo. J. Clin. Invest. 86, 1480-1488.
7. Carson, D.A., and Ribeiro, J.M. (1993). Apoptosis and disease. Lancet 341, 1251-1254.
8. Cory, S. (1995). Regulation of lymphocyte survival by the Bcl-2 gene family. Annu. Rev. Immunol. 13, 513-543.
9. Drexler, H.G., Gignac, S.M., Jones, R.A., Scott, C.S., Pettit, G.R., and Hoffbrand, A.V. (1989). Bryostatin 1 induces differentiation of B-chronic lymphocytic leukemia cells. Blood 74, 1747-1757.
10. Grant, S., Jarvis, D., Swerdlow, P.S., Turner, A.J., Traylor, R.S., Wallace, H.J., Lin, P.-S., Pettit, G.R., and Gewirtz, D.A. (1992). Potentiation of the activity of 1-β-D-arablofuranosylcytosine by the protein kinase C activator bryostatin 1 in HL-60: association with enhanced fragmentation of mature DNA. Cancer Res. 52, 6270-6278.
11. Griffig, J., Koob, R., and Blakley, R.L. (1989). Mechanisms of inhibition of DNA synthesis by 2-chlorodeoxyadenosine in human lymphoblastic cells. Cancer Res. 49, 6923-6928.
12. Hanada, M., Delia, D., Aiello, A., Stadmauer, E., and Reed, J.C. (1993). bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood 82, 1820.
13. Jarvis, D.W., Gewirt, D., Povirk, L., Turner, A.J., Traylor, R., Pettit, R.G., and Grant, S. (1994). Effect of bryostatin 1 and other activators of protein kinase C on 1-β-D-Arabiofuranosylcytosine-induced apoptosis in HL-60 human promyelocytic leukemia cells, Biochem. Pharmcol. 47, 839-852.
14. Kawasaki, H., Carrera, C.J., Piro, L.D., Saven, A., Kipps, T.J., and Carson, D.A. (1993). Relationship of deoxycytidine kinase and cytoplasmic 5′-nucleotidase to the chemotherapeutic efficacy of 2-chlorodeoxyadenosine. Blood 81, 597-601.
15. Lauria, F., Rondelll, D., Zinzani, P.L., Bocchia, M., Marotta, G., Salvucci, M., Raspadori, D., Ventura, M.A., Birtolo, M.A., Forconl, F., and Tura, S. (1997). Long-lasting complete remission in patients with hairy cell leukemia treated with 2-CdA: a 5-year survey. Leukemia 11, 629-632.
16. Liu, X., Kim, C.N., Yang, J., Jermmerson, R., and Wang, X. (1996). Induction of apoptotic program in cell-free extract: Requirement for dATP and cytochrome c. Cell 86, 147-157.
17. Madrid-Marina, V., Lestan, B., Nowak, P.J., and Fox, I.H. (1993). Altered properties of human T-lymphoblast soluble low Km 5′-nucleotidase: comparison with B-lymphoblast enzyme. Leuk. Res. 17, 231-240.
18. McConkey, D.J., Chandra, J.,Wright, S., Plunkett, W., McDonnell, T.J., Reed, J.C., and Keating, M. (1996). Apoptosis sensitively in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of Bcl-2 and Bax. J. Immunol. 156, 2624-2630.
19. Miyashita, T., and Reed, J.C. (1993). Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 81, 151-157.
20. Mohammad, R.M., Al-Katib, A., Pettit, G.R., and Sensenbrenner, L.L. (1994). Successful treatment of human Waldenstrom's macroglobulinemia with combination biological and chemotherapy agents. Cancer Res. 54, 165-168.
21. Mohammad, R.M., Diwakaran, H., Maki, A., Emara, M.A., Pettit, G.R., Redman, B., and Al-Katib, A. (1995). Bryostatin 1 induces apoptosis and augments inhibitory effects of vincristine in human diffuse large cell lymphoma. Leuk. Res. 79, 667-673.
22. Mohammad, R.M., Mohamed, A.N., Hamdan, M.Y., Vo,T., Chen, B., Katato, K., Abubakr, Y.A., Dugan, M.C., and Al-Katib, A. (1996). Establishment of a human B-CLL xenograft model: Utility as a preclinical therapeutic model. Leukemia 10, 130-137.
23. Mohammad, R.M., Katato, K., Almatchy, V.P. Wall, N., Liu, K.-Z., Schultz, C.P., Mantsch, H.H., Varterasian, M., and Al-Katib, A. (1998). Sequential treatment of human chronic lymphocytic leukemia with bryostatin 1 followed by 2-chlorodeoxyadenosine: Preclinical studies. Clin. Cancer Res. 4, 445-453.
24. Oltvai, Z.N., Milliman, C.L., and Korsmeyer, S.J. (1993). Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74, 609-619.
25. Orr, R.M., Talbot, D.C., Aherne, G.W., Fisher, T.C., Serafinowski, P., and Harrap, K.R. (1995). 2′-deoxycytidine kinase deficiency is a major determinant of 2-chloro-2′-deoxyadenosine resistance in lymphoid cell lines. Clinical Can. Res. 1, 391-398.
26. Osorio, L.M., De Santiago, A., Aguilar-Santelises, M., Mellstedt, H., and Jondal, M. (1997). CD6 ligation modulates the Bcl-2/Bax ratio and protects chronic lymphocytic leukemia B cells from apoptosis induced by anti-IgM. Blood 89, 2833-2841.
27. Pettit, G.R., Herald, C.L., Doubek, D.L., Herald, D.L., Arnold, E., and Clardy, J. (1982). Isolation and structure of Bryostatin 1.J. Am. Chem. Soc. 104, 6846-6848.
28. Philpott, N.J., Turner, A.J.C., Scopes, J., Westby, M., Marsh, J.C.W., Gordon-Smith, E.C., Dalgleish, A.G., and Gibson, F.M. (1996). The use of 7-amino actinomycin D in identifying apoptosis: Simplicity of use and broad spectrum of application compared with other techniques. Blood 87, 2244-2251.
29. Piro, L.D., Carrera, C.J., Carson, D.A., and Beutler, E. (1990). Lasting remissions in hairy cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. N. Engl. J. Med. 322, 1117-1121.
30. Piro, L.D. (1992). 2-Chlorodeoxyadenosine treatment of lymphoid malignancies. Blood 79, 843-845.
31. Saven, A., and Piro, L.D. (1994). Newer purine analogue for the treatment of hairy cell leukemia. N. Engl. J. Med. 330, 691-697.
32. Saven, A., and Piro, L.D. (1997). 2-Chlorodeoxyadenosine treatment of lymphoma. In: Advances in Lymphoma Research. Fernando Cabanillas and M. Alma Rodriguez, eds. (Boston, USA: Kluwer Academic Publishers) pp. 15-26.
33. Spasokoukotskaja, T., Arner, E.S.J., Brosjo, O., Gunven, P., Juliusson, G., Liliemark, J., and Eriksson, S. (1995). Expression of deoxycytidine kinase and phosphorylation of 2-chlorode- oxyadenosine in human normal and tumor cells and tissues. Euro. J. Cancer. 31A, 202-208.
34. Tallman, M.S., and Hakimian, D. (1995). Purine nucleoside analogs: Emerging roles in indolent lymphoproliferative disorders. Blood 86, 2463-2474.